Managing neurocysticercosis: challenges and solutions

References

• SinghGBurneoJGSanderJWFrom seizures to epilepsy and its substrates: neurocysticercosisEpilepsia20135478379223621876
   PubMed Web of Science ®Google Scholar
• OngSTalanDAMoranGJNeurocysticercosis in radiographically imaged seizure patients in US emergency departmentsEmerg Infect Dis2002860861312023918
   PubMed Web of Science ®Google Scholar
• CrokerCRedelingsMReporterRSorvilloFMascolaLWilkinsPThe impact of neurocysticercosis in California: a review of hospitalized casesPLoS Negl Trop Dis2012616
   Web of Science ®Google Scholar
• CoyleCMMahantySZuntJRNeurocysticercosis: neglected but not forgottenPLoS Negl Trop Dis201265e150022666505
   PubMed Web of Science ®Google Scholar
• Del BruttoOHGarciaHHNeurocysticercosisHandb Clin Neurol201311431332523829921
   PubMedGoogle Scholar
• NdimubanziPCCarabinHBudkeCMA systematic review of the frequency of neurocyticercosis with a focus on people with epilepsyPLoS Negl Trop Dis20104e87021072231
   PubMed Web of Science ®Google Scholar
• WinklerASRichterHLandscape analysis: management of neurocysticercosis with an emphasis on low- and middle-income countries (LMIC) Available from: http://apps.who.int/iris/bitstream/10665/152896/1/WHO_HTM_NTD_NZD_2015.05_eng.pdfAccessed May 4, 2015
   Google Scholar
• RomanGSoteloJDel BruttoOA proposal to declare neurocysticercosis an international reportable diseaseBull World Health Organ200078339940610812740
   PubMed Web of Science ®Google Scholar
• DeGiorgioCMHoustonIOviedoSSorvilloFDeaths associated with cysticercosis. Report of three cases and review of the literatureNeurosurg Focus200212e215926781
   PubMedGoogle Scholar
• FleuryACarrillo-MezoRFlisserASciuttoECoronaTSubarachnoid basal neurocysticercosis: a focus on the most severe form of the diseaseExpert Rev Anti Infect Ther2011912313321171883
   PubMed Web of Science ®Google Scholar
• BhattaraiRBudkeCMCarabinHEstimating the nonmonetary burden of neurocysticercosis in MexicoPLoS Negl Trop Dis20126e152122363827
   PubMed Web of Science ®Google Scholar
• FleuryAGomezTAlvarezIHigh prevalence of calcified silent neurocysticercosis in a rural village of MexicoNeuroepidemiology20032213914512629280
   PubMed Web of Science ®Google Scholar
• FlisserASartiELightowlersMSchantzPNeurocysticercosis: regional status, epidemiology, impact and control measures in the AmericasActa Trop200387435112781377
   PubMed Web of Science ®Google Scholar
• MurrellKDDornyPFlisserSWHO/FAO/OIE Guidelines for the surveillance, prevention and control of taeniosis/cysticercosis2005Paris, FranceOIE Available from: http://www.oie.int/doc/ged/d11245.pdfAccessed November 7, 2014
   Google Scholar
• FlisserAGyorkosTWContribution of immunodiagnostic tests to epidemiological/intervention studies of cysticercosis/taeniosis in MexicoParasite Immunol20072963764918042170
   PubMed Web of Science ®Google Scholar
• FlisserAEpidemiology of neurocysticercosis in Mexico: from a public health problem to its controlFoyaca-SibatHNovel Aspects on Cysticercosis and NeurocysticercosisRijeka, CroatiaInTech2013307340
   Google Scholar
• RajshekharVJoshiDDDoanhNQvan DeNXiaonongZTaenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issuesActa Trop200387536012781378
   PubMed Web of Science ®Google Scholar
• LiTCraigPSItoATaeniasis/cysticercosis in a Tibetan population in Sichuan Province, ChinaActa Trop200610022323117166477
   PubMed Web of Science ®Google Scholar
• CarabinHMillogoAPraetNSeroprevalence to the antigens of Taenia solium cysticercosis among residents in three villages in Burkina Faso: a cross-sectional studyPLoS Negl Trop Dis20093e55519936298
   PubMed Web of Science ®Google Scholar
• KanobanaKPraetNKabweCHigh prevalence of Taenia solium cysticercosis in a village community of Bas-Congo, Democratic Republic of CongoInt J Parasitol2011411015101821763695
   PubMed Web of Science ®Google Scholar
• MwapeKEPhiriIKPraetNTaenia solium infections in a rural area of Eastern Zambia-a community based studyPLoS Negl Trop Dis20126e159422479664
   PubMed Web of Science ®Google Scholar
• MwanjaliGKihamiaCKakokoDVPrevalence and risk factors associated with human Taenia solium infections in Mbozi District, Mbeya Region, TanzaniaPLoS Negl Trop Dis20137e210223516650
   PubMed Web of Science ®Google Scholar
• BrunoEBartoloniAZammarchiLCOHEMI Project Study GroupEpilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysisPLoS Negl Trop Dis2013710e248024205415
   PubMed Web of Science ®Google Scholar
• QuetFGuerchetMPionSDSNgoungouEBNicolettiAPreuxPMMeta-analysis of the association between cysticercosis and epilepsy in AfricaEpilepsia20105183083719919664
   PubMed Web of Science ®Google Scholar
• CruzMESchantzPMCruzIEpilepsy and neurocysticercosis in an Andean communityInt J Epidemiol19992879980310480714
   PubMed Web of Science ®Google Scholar
• EdwardsTScottAGMunyokiGActive convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factorsLancet Neurol20087505618068520
   PubMed Web of Science ®Google Scholar
• WinklerASKerschbaumsteinerKStelzhammerBMeindlMKaayaJSchmutzhardEPrevalence, incidence and clinical characteristics of epilepsy – a community-based door-to-door study in northern TanzaniaEpilepsia2009502310231319583783
   PubMed Web of Science ®Google Scholar
• SerpaJAGravissEAKassJSWhiteACJrNeurocysticercosis in Houston, Texas: an updateMedicine (Baltimore)2011901818621200189
   PubMed Web of Science ®Google Scholar
• SorvilloFWilkinsPShafirSEberhardMPublic health implications of cysticercosis acquired in the United StatesEmerg Infect Dis20111711621192847
   PubMed Web of Science ®Google Scholar
• MedinaMTAguilar-EstradaRLAlvarezAReduction in rate of epilepsy from neurocysticercosis by community interventions: the Salamá, Honduras studyEpilepsia20115261177118521275975
   PubMed Web of Science ®Google Scholar
• SoteloJDiaz-OlavarrietaCNeurocysticercosis: changes after 25 years of medical therapyArch Med Res2010411626320430257
   PubMed Web of Science ®Google Scholar
• SchantzPMMooreACMuñozJLNeurocysticercosis in an Orthodox Jewish community in New York CityN Engl J Med1992327106926951495521
   PubMed Web of Science ®Google Scholar
• GarciaHHDel BruttoOHNeurocysticercosis: updated concepts about an old diseaseLancet Neurol2005465366116168934
   PubMed Web of Science ®Google Scholar
• EstanolBCoronaTAbadPA prognostic classification of cerebral cysticercosis: therapeutic implicationsJ Neurol Neurosurg Psychiatr198649113111343783174
   PubMed Web of Science ®Google Scholar
• CarabinHNdimubanziPCBudkeCMClinical manifestations associated with neurocysticercosis: a systematic reviewPLoS Negl Trop Dis20115e115221629722
   PubMed Web of Science ®Google Scholar
• NashTEGarciaHHRajshekharVDel BruttoOHClinical cysticercosis: diagnosis and treatmentMurrellKDWHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis/CysticercosisParis, FranceOIE20057399
   Google Scholar
• NashTEMahantySLoebJANeurocysticercosis: a natural human model of epileptogenesisEpilepsia201556217718310.1111/epi.1284925534640
   PubMed Web of Science ®Google Scholar
• SerpaJAYanceyLSWhiteACJrAdvances in the diagnosis and management of neurocysticercosisExpert Rev Anti Infect Ther200641051106117181420
   PubMedGoogle Scholar
• MishraDCysticercosis headache: an important differential of childhood headache disorder in endemic countriesHeadache20074730130217300377
   PubMed Web of Science ®Google Scholar
• FogangYFCamaraMDiopAGNdiayeMMCerebral neurocysticercosis mimicking or comorbid with episodic migraine?BMC Neurol20141413824980846
   PubMed Web of Science ®Google Scholar
• Del BruttoOHDel BruttoVJCalcified neurocysticercosis among patients with primary headacheCephalalgia201132325025422174352
   PubMed Web of Science ®Google Scholar
• CruzMECruzIPreuxPMSchantzPDumasMHeadache and cysticercosis in Ecuador, South AmericaHeadache199535293977737869
   PubMed Web of Science ®Google Scholar
• GarciaHHNashTEDel BruttoOHClinical symptoms, diagnosis, and treatment of neurocysticercosisLancet Neurol2014131202121525453460
   PubMed Web of Science ®Google Scholar
• LeonASaitoEKMehtaBMcMurtrayAMCalcified parenchymal central nervous system cysticercosis and clinical outcomes in epilepsyEpilepsy Behav201543C778025569744
   PubMed Web of Science ®Google Scholar
• NashTEGarciaHHDiagnosis and treatment of neurocysticercosisNat Rev Neurol2011758459421912406
   PubMed Web of Science ®Google Scholar
• WinklerASEpilepsy and neurocysticercosis in sub-Saharan AfricaFoyaca-SibatHNovel Aspects on Cysticercosis and NeurocysticercosisRijeka, CroatiaInTech2013307340
   Google Scholar
• RangelRTorresBDel BruttoOSoteloJCysticercotic encephalitis: a severe form in young femalesAm J Trop Med Hyg1987363873923826497
   PubMed Web of Science ®Google Scholar
• TakayanaguiOMOdashimaNSBonatoPSLimaJELanchoteVLMedical management of neurocysticercosisExpert Opin Pharmacother2011122845285622082143
   PubMed Web of Science ®Google Scholar
• PalDKCarpioASanderJWNeurocysticercosis and epilepsy in developing countriesJ Neurol Neurosurg Psychiatr20006813714310644776
   PubMed Web of Science ®Google Scholar
• Del BruttoOHRajshekharVWhiteACJrProposed diagnostic criteria for neurocysticercosisNeurology20015717718311480424
   PubMed Web of Science ®Google Scholar
• Del BruttoOHSantibanezRIdrovoLEpilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal EcuadorEpilepsia20054658358715816956
   PubMed Web of Science ®Google Scholar
• NashTEDel BruttoOHButmanJACalcific neurocysticercosis and epileptogenesisNeurology2004621934193815184592
   PubMed Web of Science ®Google Scholar
• NashTESinghGWhiteACTreatment of neurocysticercosis: current status and future research needsNeurology2006671120112717030744
   PubMed Web of Science ®Google Scholar
• TsangVCBrandJABoyerAEAn enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium)J Infect Dis198915950592909643
   PubMed Web of Science ®Google Scholar
• RodriguezSDornyPTsangVCDetection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosisJ Infect Dis20091991345135219358669
   PubMed Web of Science ®Google Scholar
• Del BruttoOHDiagnostic criteria for neurocysticercosis, revisitedPathog Glob Health201210629930423265554
   PubMed Web of Science ®Google Scholar
• Machado LdosRThe diagnosis of neurocysticercosis: a closed question?Arq Neuropsiquiatr2010681220339642
   PubMed Web of Science ®Google Scholar
• GarciaHHGonzalezAERodriguezSNeurocysticercosis: unraveling the nature of the single cysticercal granulomaNeurology20107565465820713953
   PubMed Web of Science ®Google Scholar
• GarciaHHEvansCANashTECurrent consensus guidelines for treatment of neurocysticercosisClin Microbiol Rev20021574775612364377
   PubMed Web of Science ®Google Scholar
• GarciaHHGonzalezAEGilmanRHCysticercosis of the central nervous system: how should it be managed?Curr Opin Infect Dis20112442342721788891
   PubMed Web of Science ®Google Scholar
• WinklerASWillinghamAL3rdSikasungeCSSchmutzhardEEpilepsy and neurocysticercosis in sub-Saharan AfricaWien Klin Wochenschr2009121Suppl 3S3S1219915987
   PubMed Web of Science ®Google Scholar
• SinghGRajshekharVMurthyJMA diagnostic and therapeutic scheme for a solitary cysticercus granulomaNeurology2010752236224521172847
   PubMed Web of Science ®Google Scholar
• GonzalesIGarciaHHCurrent status and future perspectives on the medical treatment of neurocysticercosisPathog Glob Health201210630530923265555
   PubMed Web of Science ®Google Scholar
• WinklerASNeurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and managementPathog Glob Health201210626127423265550
   PubMed Web of Science ®Google Scholar
• MontanoSMVillaranMVYlquimicheLNeurocysticercosis: association between seizures, serology, and brain CT in rural PeruNeurology20056522923316043791
   PubMed Web of Science ®Google Scholar
• BlocherJSchmutzhardEWilkinsPPA cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approachesPLoS Negl Trop Dis20115e118521666796
   PubMed Web of Science ®Google Scholar
• TakayanaguiOMJardimETherapy for neurocysticercosis. Comparison between albendazole and praziquantelArch Neurol1992492902941536632
   PubMedGoogle Scholar
• GarciaHHGilmanRHHortonJAlbendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in PeruNeurology199748142114279153484
   PubMed Web of Science ®Google Scholar
• CardenasGCarrillo-MezoRJungHSciuttoEHernandezJLFleuryASubarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case seriesBMC Neurol2010101620202200
   PubMed Web of Science ®Google Scholar
• NashTEMahantySGarciaHHCysticercosis Group in Peru. Corticosteroid use in neurocysticercosisExpert Rev Neurother2011111175118321797658
   PubMed Web of Science ®Google Scholar
• GarciaHHGonzalesILescanoAGCysticercosis Working Group in Peru. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early afterEpilepsia2014551452145925092547
   PubMed Web of Science ®Google Scholar
• MallRKAgarwalAGargRKKarAWShuklaRShort course of prednisolone in Indian patients with solitary cysticercus granuloma and new onset seizuresEpilepsia2003441397140114636346
   PubMed Web of Science ®Google Scholar
• GargRKPotluriNKarAMShort course of prednisolone in patients with cysticercus granuloma: a double blind placebo controlled trialJ Infect200653656916269179
   PubMed Web of Science ®Google Scholar
• PrakashSGargRKKarAMIntravenous methylprednisolone in patients with solitary cysticercus granuloma: a random evaluationSeizure20061532832316621618
   PubMed Web of Science ®Google Scholar
• KishoreDMisraSA short course of oral prednisolone on disappearance of lesion and seizure recurrence in patients of solitary cysticercus granuloma with single small enhancing CT lesion: an open label randomized prospective studyJ Assoc Physicians India20075541942417879495
   PubMedGoogle Scholar
• KeiserPBNashTEProlonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agentClin Infect Dis200336e122e12612746791
   PubMed Web of Science ®Google Scholar
• GarciaHHPretellEJGilmanRHA trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosisN Engl J Med200435024925814724304
   PubMed Web of Science ®Google Scholar
• SoteloJDel BruttoOHPenagosPComparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosisJ Neurol199023769722192018
   PubMed Web of Science ®Google Scholar
• Del BruttoOHRoosKLCoffeyCSGarciaHHMeta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantelAnn Intern Med2006145435116818928
   PubMed Web of Science ®Google Scholar
• BairdRAWiebeSZuntJRHalperinJJGronsethGRoosKLEvidence-based guideline: treatment of parenchymal neurocysticercosis: report of the guideline development subcommittee of the American academy of neurologyNeurology201380151424142923568997
   PubMed Web of Science ®Google Scholar
• CastroNMarquez-CaraveoCBrundageRCPopulation pharmacokinetics of albendazole in patients with neurocysticercosisInt J Clin Pharmacol Ther20094767968519840532
   PubMed Web of Science ®Google Scholar
• Gongora-RiveraFSoto-HernandezJLGonzalez EsquivelDAlbendazole trial at 15 or 30 mg/kg/day for subarachnoid and intra-ventricular cysticercosisNeurology20066643643816382035
   PubMed Web of Science ®Google Scholar
• RajshekharVAlbendazole therapy for persistent solitary cysticercus granulomas in patients with seizuresNeurology199343123812408170573
   PubMed Web of Science ®Google Scholar
• ThussuAChattopadhyayASawhneyIMKhandelwalNAlbendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsyJ Neurol Neurosurg Psychiatr20087927227517928325
   PubMed Web of Science ®Google Scholar
• SinghMKGargRKNathGVermaDNMisraSSingle small enhancing computed tomographic (CT) lesions in Indian patients with new-onset seizures. A prospective follow-up in 75 patientsSeizure20011057357811792159
   PubMed Web of Science ®Google Scholar
• PretellEJGarciaHHCustodioNShort regimen of praziquantel in the treatment of single brain enhancing lesionsClin Neurol Neurosurg200010221521811154807
   PubMed Web of Science ®Google Scholar
• Medina-SantillanRMateos-GarciaEReyes-GarciaGCastaneda-HernandezGSoteloJPharmacoeconomic analysis of the short scheme praziquantel in the treatment of neurocysticercosisGac Med Mex200213820320712001432
   PubMedGoogle Scholar
• PretellEJGarciaHHGilmanRHSaavedraHMartinezMCysticercosis Working Group in Peru. Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesionsClin Neurol Neurosurg200110317517711532559
   PubMed Web of Science ®Google Scholar
• SoteloJJungHPharmacokinetic optimisation of the treatment of neurocysticercosisClin Pharmacokinet1998345035159646011
   PubMed Web of Science ®Google Scholar
• CarpioASantillanFLeonPFloresCHauserWAIs the course of neurocysticercosis modified by treatment with anthelmintic agents?Arch Intern Med1995155198219887575052
   PubMed Web of Science ®Google Scholar
• MaigaYDialloMBouteilleBAbout an autochtonous case of neurocysticercosis in MaliBull Soc Pathol Exot200910221121419950534
   PubMedGoogle Scholar
• SoteloJMarinCHydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 casesJ Neurosurg1987666866893572494
   PubMed Web of Science ®Google Scholar
• Suastegui RomanRASoto-HernandezJLSoteloJEffects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary studyJ Neurosurg1996846296338613855
   PubMed Web of Science ®Google Scholar
• GabrielSBlocherJDornyPAdded value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settingsPLoS Negl Trop Dis20126e185123094118
   PubMed Web of Science ®Google Scholar
• SchantzPMCruzMSartiEPawlowskiZPotential eradicability of taeniasis and cysticercosisBull Pan Am Health Organ1993273974038312963
   PubMedGoogle Scholar
• Del BruttoOHNeurocysticercosisContinuum Lifelong Learn Neurol201218613921416
   Google Scholar
• Del BruttoOHGarciaHHCysticercosis of the Human Nervous SystemBerlin, Germany; Berlin HeidelbergSpringer2014
   Google Scholar
• PondjaANevesLMlangwaJUse of oxfendazole to control porcine cysticercosis in a high-endemic area of MozambiquePLoS Med20126515
   Google Scholar
• NascimentoECostaJOGuimaraesMPTavaresCAEffective immune protection of pigs against cysticercosisVet Immunol Immunopathol1995451–21271377604530
   PubMed Web of Science ®Google Scholar
• PlancarteAFlisserAGauciCGLightowlersMWVaccination against Taenia solium cysticercosis in pigs using native and recombinant oncosphere antigensInt J Parasitol199929464364710428641
   PubMed Web of Science ®Google Scholar
• VerasteguiMGilmanRHGonzalezAETaenia solium oncosphere antigen induce immunity in pigs against experimental cysticercosisVet Parasitol2002108496212191899
   PubMed Web of Science ®Google Scholar
• FlisserAGauciCGZoliAInduction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigensInfect Immun20047295292529715322025
   PubMed Web of Science ®Google Scholar
• GonzalezAEGauciCGBarberDVaccination of pigs to control human neurocysticercosisAm J Trop Med Hyg200572683783915964973
   PubMed Web of Science ®Google Scholar
• AssanaEKyngdonCTGauciCGElimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in CameroonInt J Parasitol200240551551920138046
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionCysticercosisAtlanta, GACenters for disease control and prevention Available from: http://www.cdc.gov/parasites/cysticercosis/biology.htmlAccessed July 6, 2015
   Google Scholar